Key facts
- Notable investors include Daan Incubator, Daoyuan Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Aona Regenerative Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Aona Regenerative Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aona Regenerative Medicine
Manufacturer of biochemical products intended for healthcare and research purposes. The company offers the production of protective medical supplies, the development of biotechnological materials, the creation of anti-aging formulations, and the distribution of health-related consumer goods, enabling clients to access reliable tools, broaden research applications, improve patient safety, and support advancements in regenerative medicine through diversified product offerings and technical services.
- Sector
- Healthcare
- HQ
- Zhuhai, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Aona Regenerative Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aona Regenerative Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aona Regenerative Medicine in its N-PORT filings yet. We sweep new filings monthly.